← Eichor
Study identifier: NCT06848946 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Safety and Efficacy of iDose® TR With Cataract Surgery vs. Cataract Surgery Alone

Condition: Glaucoma, Open-angle · Ocular Hypertension (OHT) · Phacoemulsification Cataract Surgery  ·  Sponsor: Glaukos Corporation

PhasePhase 4
Planned participants132
Who can joinAll sexes, 45 Years to no upper limit
Healthy volunteersNo

About this study

This trial will evaluate the safety and IOP -lowering efficacy of administering an iDose TR (travoprost intracameral implant) in conjunction with cataract surgery compared to cataract surgery alone

This description comes directly from the study's public registry record.

Talk to the study team

Study Manager  ·  949-739-8749  ·  ClinicalResearch@glaukos.com

Always discuss trial participation with your own doctor first.

Locations (1)

Glaukos Investigator SiteKenosha, Wisconsin, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06848946